Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.6 USD | +2.36% | +22.27% | -3.37% |
May. 02 | Cyclacel Pharmaceuticals, Inc. announced that it has received $8.000001 million in funding | CI |
Apr. 30 | Top Midday Gainers | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.37% | 3.72M | |
+4.00% | 111B | |
+11.42% | 105B | |
-13.01% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.29% | 16.96B | |
+2.44% | 13.7B | |
+36.07% | 12.45B |
- Stock Market
- Equities
- CYCC Stock
- News Cyclacel Pharmaceuticals, Inc.
- Transcript : Cyclacel Pharmaceuticals, Inc., Q3 2019 Earnings Call, Nov 13, 2019